This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Marijuana Industry To Reach $9B/Year Valuation By 2017, Rivaling Beer & Wine

WOODLAND HILLS, Calif., Dec. 4, 2012 /PRNewswire/ -- GrowLife Inc. (OTCBB: PHOT) is a dedicated company focused on providing the blossoming marijuana industry with the highest quality growing products available, while still complying with all federal and state laws.

GrowLife is proud to announce its endorsement of a recent article drawing correlations between the exploding $1.7B/year marijuana industry, and the beer and wine industries.  Amid ongoing legalization efforts, a report from financial news firm 'See Change Strategy' predicts the marijuana market could reach $9B/year by 2017, a 429% growth in the industry.  

Of all the publicly traded companies looking to capitalize on the 'green rush,' GrowLife has been able to position themselves as the industry leader when it comes to affordable, high end indoor/outdoor gardening equipment for hobbyist and commercial growers alike. 

There are many who feel that the size of the marijuana market has the potential to rival that of the beer and wine industry.  It is estimated that 100 million Americans have tried marijuana in their lives, with 28 million having used marijuana in the last 12 months.  Compare that to a Gallup poll from this spring that states a full 34% of Americans never drink alcohol, and an additional 52% are considered to be 'occasion' drinkers where they only drink when in social settings.  

Read the full Long Beach Business Journal article at the following link:

http://www.lbbusinessjournal.com/long-beach-business-journal-newswatch/173-12-11-20/1085-the-business-of-medical-marijuana.html

Key highlights in the article included:

  • Cliff Schaffer, editor of MarijuanaBusinessNews.com, indicated his belief that the marijuana industry has the potential to rival the size of the beer and wine industry, with municipalities benefiting from tax revenues in much the same way
  • Tripp Keber, managing director of Dixie Elixirs and Edibles LLC, which produces 65 marijuana-infused products in Denver, CO, added that "Big Alcohol, Big Tobacco and Big Pharma clearly are watching" these industry trends.
  • Predicts that the market could reach nearly $9 billion in the U.S. over the next five years, as some states are likely to legalize marijuana for medical purposes and others likely to legalize marijuana for recreational purposes.
  • California spends an estimated $2 billion each year enforcing prohibition, according to Jeffrey Miron, director of undergraduate studies at Harvard University, and the resources needed for these efforts are rising each year.

 "GrowLife is well positioned as a completely legal play on the blossoming marijuana industry," added Sterling Scott, the CEO of GrowLife, Inc. "Our industry-leading horticulture products are uniquely suited to give the marijuana plant exactly what it needs to produce high quality flowers with maximum levels of essential oils and resins. With Colorado expected to allow six indoor marijuana plants per household, we believe there is enormous potential for our end-to-end growing solutions easy enough for anyone to operate."

GrowLife's consortium of companies actively participate in all channels of commerce for distribution and sales, including operating on-line and retail outlets for direct consumer sales and the supply of specialty GrowLife company products to wholesale and retail channels. And, while supporting progressive normalization of cannabis laws, the company does not grow, sell or distribute any substances that violate U.S. law or the Federal Controlled Substances Act.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs